13:53 IST
BSE
Other AnnouncementMedicamen Biotech Ltd MEDICAMEQ
Medicamen Biotech Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Medicamen Biotech other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Medicamen Biotech Limited's Director Sanjay Bansal sold 32,813 shares on the open market, as per a regulatory filing.
Medicamen Biotech Ltd clarified that an event reflected on the NSDL portal under its credentials was displayed inadvertently and incorrectly. The company confirmed no such event was authorized or initiated and is working with NSDL for rectification. There is no material information requiring disclosure at this time.